Shimon Slavin (; born 17 May 1941) is an Israeli professor of medicine. Born in Tel Aviv, he moved to Jerusalem with his family in 1946, and resided there until 2007.
In 2016, Slavin contributed to other Hadassah Medical Center doctors' efforts of transplantation of stem cells.Stem cell therapy trial for ALS and MS patients at Jerusalem hospital shows stunning results That same year, International Center for Cell Therapy & Cancer Immunotherapy (CTCI), of which Slavin served as the medical and scientific director, was closed down by Israeli government. His medical license was suspended for six months by the Ministry of Health in 2017, and for another entire year in Janurary 2018. In the latter decision, judge Amnon Strashnov found Slavin to have violated medical ethics and medical law, commented on the previous 6-month suspension as "too far [...] in favor of the defendant [Slavin]", and describing him as committing "serious negligence in fulfilling his duties as a doctor", and that "his greatness is matched only by the depth of his fall". In the same investigation, it was revealed that two patients died after receiving treatment at the clinic.
Published works Books
See also
Stem cell controversy Cancer immunotherapy
References